Researchers track Real-World safety of new cholesterol combo
NCT ID NCT07206472
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 27 times
Summary
This study is observing over 2,500 adults with high cholesterol or mixed dyslipidemia who are taking bempedoic acid (alone or with ezetimibe) as part of their normal care. The goal is to see how safe and effective the drug is in real-world settings, especially in Asian and Latin American patients. No new treatments are given—just monitoring of side effects and heart risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Instituto do Coração do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo - InCor HCFMUSP
São Paulo, 05403-000, Brazil
Conditions
Explore the condition pages connected to this study.